Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Glioma 2Pheochromocytoma 1Parkinsonian Disorders 1Neoplasms 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Endocrine System Diseases 1Congenital Hyperinsulinism 1Carcinoid Tumor 1Brain Neoplasms 1Beckwith-Wiedemann Syndrome 1

Interventions

Specimen Handling 3Magnetic Resonance Spectroscopy 3olaparib 2lutetium Lu 177 dotatate 2gallium Ga 68 dotatate 2Fluorodeoxyglucose F18 26-fluorodopamine 2tipifarnib 1fluorodopa F 18 1fludarabine phosphate 1belzutifan 1Temozolomide 1Nivolumab 1Ipilimumab 1Interleukin-13 1Cyclophosphamide 1Contrast Media 1CTLA-4 Antigen 1Biopsy 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pheochromocytoma × fluorodopa F 18 × 90 days × Clear all
NCT00004847 2026-06-03

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
3,000 enrolled
Endocrine

Endocrine System Diseases, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡